EyeWorld Weekly, April 25, 2025
Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
During the COVID-19 pandemic, ophthalmic practices turned to telemedicine to stay in contact with patients and get them the care they needed. In this article, two physicians discussed their experience with telemedicine, including how they saw its applications evolve and thoughts on the future potential of telehealth options.
ASCRS Subspecialty Day will take place on Friday, April 25, ahead of the official kickoff of the main 2025 ASCRS Annual Meeting. This year, attendees can expect exciting programs focusing on refractive, cornea, and glaucoma topics. The program chairs discussed what they’re looking forward to.
➤ Study: long-term efficacy of uveoscleral outflow enhancement for glaucoma ➤ FDA grants expanded indication for fluocinolone acetonide intravitreal implant ➤ First patient dosed in Phase 1/2 gene therapy trial targeting Stargardt disease ➤ Merger complete ➤ ASCRS news and events
➤ FDA accepts new drug application for pharmaceutical aiming to treat pediatric myopia ➤ FDA approves treatment for macular telangiectasia type 2 ➤ Survey reveals perspectives of patients with glaucoma ➤ New wearable vision testing platform ➤ Seeking Fast Track Designation for investigational treatment of neuropathic corneal pain ➤ Fast Track Designation granted to gene therapy targeting X-linked retinoschisis ➤ ASCRS news and events
➤ Proof-of-concept trial for intravitreal implant for glaucoma patients ➤ Phase 3 study evaluating intravitreal gene therapy for wet AMD ➤ New analysis shows differentiation of investigational glaucoma treatment ➤ IND studies to investigate gene therapy for dry AMD ➤ ASCRS news and events
➤ FDA approves new viscoelastic system ➤ Expanded label approved for geographic atrophy treatment ➤ Biologics application accepted for aflibercept biosimilar ➤ Update on gene therapy program ➤ ASCRS news and events
In his introduction to the “Interventional glaucoma” bonus issue of EyeWorld, Chief Medical Editor Sumit “Sam” Garg, MD, shared some of his personal experiences in this space and what topics readers can expect to learn more about.
Glaucoma Editor Manjool Shah, MD, provided his thoughts on the evolution of interventional glaucoma.
MIGS has continued to expand in its application for a wide variety of patients with varying degrees of glaucoma. Several physicians discussed where various MIGS procedures fit into interventional glaucoma, including applications for standalone MIGS and how it continues to play a role in conjunction with cataract surgery.